Ping Wei

8.2k total citations · 6 hit papers
111 papers, 5.9k citations indexed

About

Ping Wei is a scholar working on Molecular Biology, Cancer Research and Oncology. According to data from OpenAlex, Ping Wei has authored 111 papers receiving a total of 5.9k indexed citations (citations by other indexed papers that have themselves been cited), including 77 papers in Molecular Biology, 40 papers in Cancer Research and 26 papers in Oncology. Recurrent topics in Ping Wei's work include RNA modifications and cancer (24 papers), Cancer-related molecular mechanisms research (17 papers) and Cancer, Hypoxia, and Metabolism (12 papers). Ping Wei is often cited by papers focused on RNA modifications and cancer (24 papers), Cancer-related molecular mechanisms research (17 papers) and Cancer, Hypoxia, and Metabolism (12 papers). Ping Wei collaborates with scholars based in China, United States and France. Ping Wei's co-authors include Xiang Du, Senlin Zhao, Keping Xie, Dawei Li, Xinxiang Li, Nu Zhang, Dawei Li, Suyun Huang, Xuefeng He and Xinyang Zhong and has published in prestigious journals such as Nature, Journal of Clinical Investigation and Nature Communications.

In The Last Decade

Ping Wei

106 papers receiving 5.9k citations

Hit Papers

Tumor-derived exosomal miR-934 in... 2011 2026 2016 2021 2020 2018 2011 2022 2022 100 200 300 400 500

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Ping Wei China 39 4.4k 2.8k 1.2k 743 583 111 5.9k
Amaia Lujambio United States 27 4.2k 1.0× 2.8k 1.0× 1.2k 1.1× 764 1.0× 631 1.1× 54 6.1k
Wenting Liao China 37 3.8k 0.9× 2.3k 0.8× 1.2k 1.1× 409 0.6× 460 0.8× 95 5.0k
Songqing Fan China 41 3.8k 0.9× 1.7k 0.6× 1.6k 1.4× 599 0.8× 647 1.1× 185 5.2k
Heike Allgayer Germany 44 4.9k 1.1× 4.0k 1.5× 1.9k 1.6× 702 0.9× 699 1.2× 131 7.3k
Elvira Pelosi Italy 47 4.5k 1.0× 2.3k 0.8× 1.5k 1.3× 1.4k 1.9× 707 1.2× 170 7.9k
Ana I. Robles United States 46 5.3k 1.2× 2.6k 0.9× 2.4k 2.1× 692 0.9× 692 1.2× 93 7.5k
Yujuan Zhou China 34 3.0k 0.7× 2.0k 0.7× 1.1k 0.9× 829 1.1× 560 1.0× 72 4.6k
Tiebang Kang China 51 6.3k 1.5× 3.4k 1.2× 2.4k 2.1× 832 1.1× 712 1.2× 156 8.9k
Gong Yang China 45 2.8k 0.6× 1.5k 0.5× 1.4k 1.2× 625 0.8× 461 0.8× 108 5.0k
Jing‐Ping Yun China 41 3.5k 0.8× 2.5k 0.9× 1.6k 1.4× 645 0.9× 863 1.5× 151 5.8k

Countries citing papers authored by Ping Wei

Since Specialization
Citations

This map shows the geographic impact of Ping Wei's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ping Wei with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ping Wei more than expected).

Fields of papers citing papers by Ping Wei

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ping Wei. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ping Wei. The network helps show where Ping Wei may publish in the future.

Co-authorship network of co-authors of Ping Wei

This figure shows the co-authorship network connecting the top 25 collaborators of Ping Wei. A scholar is included among the top collaborators of Ping Wei based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ping Wei. Ping Wei is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Zhang, Kaimin, Tingcun Zhao, Yikui Li, et al.. (2025). Neuritin-specific antibody impedes the Treg-mediated suppression of anti-tumor immunity and enhances response to anti-PD1. Molecular Immunology. 181. 148–159.
2.
Chen, Jiayu, Yuxue Li, Xuefeng He, et al.. (2025). Huaier overcomes tumor-induced immunosuppression in colorectal cancer by activating MHC I and CD8+ T cells. Phytomedicine. 147. 157157–157157.
3.
Islam, Md. Sharifull, Ping Wei, Ishatur Nime, et al.. (2024). The interplay of factors in metabolic syndrome: understanding its roots and complexity. Molecular Medicine. 30(1). 279–279. 30 indexed citations
4.
Fu, Xiuping, et al.. (2024). Associations of Schizophrenia and Major Depressive Disorder with Constipation: A Mendelian Randomization Study. Clinical and Experimental Gastroenterology. Volume 17. 349–357. 1 indexed citations
5.
Huang, Huixia, Keji Chen, Yifei Zhu, et al.. (2024). A multi-dimensional approach to unravel the intricacies of lactylation related signature for prognostic and therapeutic insight in colorectal cancer. Journal of Translational Medicine. 22(1). 211–211. 48 indexed citations breakdown →
6.
Zhao, Senlin, Bingjie Guan, Yushuai Mi, et al.. (2021). LncRNA MIR17HG promotes colorectal cancer liver metastasis by mediating a glycolysis-associated positive feedback circuit. Oncogene. 40(28). 4709–4724. 70 indexed citations
7.
Li, Ming, Anqi Li, Shuling Zhou, et al.. (2020). RNA-binding protein MSI2 isoforms expression and regulation in progression of triple-negative breast cancer. Journal of Experimental & Clinical Cancer Research. 39(1). 92–92. 30 indexed citations
8.
Ni, Xuhao, Jin‐Hui Tao, Joseph Barbi, et al.. (2018). YAP Is Essential for Treg-Mediated Suppression of Antitumor Immunity. Cancer Discovery. 8(8). 1026–1043. 168 indexed citations
9.
Ning, Yan, et al.. (2018). The non‐coding RNA OTUB1‐isoform2 promotes ovarian tumour progression and predicts poor prognosis. Journal of Cellular and Molecular Medicine. 22(10). 4794–4806. 6 indexed citations
10.
Ji, Huanhuan, Lin Song, Yuxia Guo, et al.. (2018). Adverse drug events in Chinese pediatric inpatients and associated risk factors: a retrospective review using the Global Trigger Tool. Scientific Reports. 8(1). 2573–2573. 21 indexed citations
11.
Hu, S., et al.. (2017). [Prevalence and risk factors of allergic rhinitis: a Meta-analysis].. PubMed. 31(19). 1485–1491. 17 indexed citations
12.
Xu, Mi‐die, Yiqin Wang, Weiwei Weng, et al.. (2016). A Positive Feedback Loop of lncRNA- PVT1 and FOXM1 Facilitates Gastric Cancer Growth and Invasion. Clinical Cancer Research. 23(8). 2071–2080. 206 indexed citations
13.
Li, Qingguo, Yi Qin, Ping Wei, et al.. (2016). Gas1 Inhibits Metastatic and Metabolic Phenotypes in Colorectal Carcinoma. Molecular Cancer Research. 14(9). 830–840. 50 indexed citations
14.
Shen, Chen‐Yang, Yiqin Wang, Ping Wei, & Xiang Du. (2016). BRCA1-associated protein 1 deficiency in lung adenocarcinoma predicts poor outcome and increased tumor invasion. BMC Cancer. 16(1). 670–670. 8 indexed citations
15.
Liu, Zebing, Ping Wei, Yu Yang, et al.. (2015). BATF2 Deficiency Promotes Progression in Human Colorectal Cancer via Activation of HGF/MET Signaling: A Potential Rationale for Combining MET Inhibitors with IFNs. Clinical Cancer Research. 21(7). 1752–1763. 31 indexed citations
16.
Chi, Yayun, Weixiang Chen, Xiaochen Chen, et al.. (2015). Immunohistochemistry and microsatellite instability analysis in molecular subtyping of colorectal carcinoma based on mismatch repair competency.. PubMed Central. 8(11). 20988–1000. 46 indexed citations
17.
Xia, Zhibo, Ping Wei, Heng Zhang, et al.. (2013). AURKA Governs Self-Renewal Capacity in Glioma-Initiating Cells via Stabilization/Activation of β-catenin/Wnt Signaling. Molecular Cancer Research. 11(9). 1101–1111. 60 indexed citations
18.
Li, Dawei, Ping Wei, Zhihai Peng, et al.. (2012). The Critical Role of Dysregulated FOXM1–PLAUR Signaling in Human Colon Cancer Progression and Metastasis. Clinical Cancer Research. 19(1). 62–72. 94 indexed citations
19.
Li, Dawei, Zhihai Peng, Huamei Tang, et al.. (2011). KLF4-Mediated Negative Regulation of IFITM3 Expression Plays a Critical Role in Colon Cancer Pathogenesis. Clinical Cancer Research. 17(11). 3558–3568. 94 indexed citations
20.
Wei, Ping, Marlena Walls, Ming Qiu, et al.. (2010). Evaluation of Selective γ-Secretase Inhibitor PF-03084014 for Its Antitumor Efficacy and Gastrointestinal Safety to Guide Optimal Clinical Trial Design. Molecular Cancer Therapeutics. 9(6). 1618–1628. 158 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026